MoneyWorks4Me

Ajanta Pharma reports 35% rise in Q4 net profit

27 Apr 2012 Evaluate

Ajanta Pharma has reported results for fourth quarter ended March 31, 2012.

On the standalone basis, the company has posted a rise of 35.11% in its net profit at Rs 23.59 crore for the quarter ended March 31, 2012 as compared to Rs 17.46 crore for the same quarter in the previous year. Total income has increased by 39.83% at Rs 176.10 crore for quarter under review as compared to Rs 125.94 crore for the quarter ended March 31, 2011.

For the full year ended March 31, 2012, on the consolidated basis, the company has posted a rise of 52.36% in its net profit at Rs 77.26 crore for the year ended March 31, 2012 as compared to Rs 50.71 crore for the same period in the previous year. Total income has increased by 35.80% at Rs 677.39 crore for year under review as compared to Rs 498.82 crore for the period ended March 31, 2011.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.00
View more..